Distinct neurological disorders with ATP1A3 mutations

The Lancet Neurology

Volumn 13, Issue 5, 2014, Pages 503-514

  Heinzen, Erin L ^a   Arzimanoglou, Alexis ^b,c   Brashear, Allison ^d   Clapcote, Steven J ^e   Gurrieri, Fiorella ^f   Goldstein, David B ^a   Jóhannesson, Sigurdur H ^g   Mikati, Mohamad A ^a   Neville, Brian ^h   Nicole, Sophie ^c,i,j   Ozelius, Laurie J ^k   Poulsen, Hanne ^l,m   Schyns, Tsveta ⁿ   Sweadner, Kathleen J ^o   van den Maagdenberg, Arn ^p   Vilsen, Bente ^l  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b University Medical Hospital of Lyon   (France)

^c CNRS   (France)

^d WAKE FOREST SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF LEEDS   (United Kingdom)

^f CATHOLIC UNIVERSITY   (Italy)

^g AHC Federation of Europe and AHC Association of Iceland   (Iceland)

^h UNIVERSITY COLLEGE LONDON   (United Kingdom)

ⁱ INSERM   (France)

^j SORBONNE UNIVERSITÉ   (France)

^k MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^l AARHUS UNIVERSITY   (Denmark)

^m DANISH NATIONAL RESEARCH FOUNDATION   (Denmark)

ⁿ European Network for Research on Alternating Hemiplegia (ENRAH)   (Belgium)

^o MASSACHUSETTS GENERAL HOSPITAL   (United States)

^p LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); NA K ATPASE ALPHA 3; UNCLASSIFIED DRUG;

BIOLOGICAL ACTIVITY; CHILDHOOD DISEASE; DROSOPHILA; DYSTONIA; ENZYME ACTIVITY; FIBROBLAST; GENE MUTATION; GENOTYPE PHENOTYPE CORRELATION; HEMIPLEGIA; HUMAN; IN VITRO STUDY; NEUROLOGIC DISEASE; NONHUMAN; PARKINSONISM; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVIEW; ZEBRA FISH;

ANIMALS; DATABASES, BIBLIOGRAPHIC; GENETIC PREDISPOSITION TO DISEASE; HEMIPLEGIA; HUMANS; MODELS, MOLECULAR; MUTATION; NERVOUS SYSTEM DISEASES; PARKINSON DISEASE; SODIUM-POTASSIUM-EXCHANGING ATPASE;

EID: 84898406777     PISSN: 14744422     EISSN: 14744465     Source Type: Journal    
DOI: 10.1016/S1474-4422(14)70011-0     Document Type: Review

References (89)

1. Boycott KM, Vanstone MR, Bulman DE, MacKenzie AE Rare-disease genetics in the era of next-generation sequencing: discovery to translation. Nat Rev Genet 2013, 14:681-691.
2. McGrail KM, Phillips JM, Sweadner KJ Immunofluorescent localization of three Na,K-ATPase isozymes in the rat central nervous system: both neurons and glia can express more than one Na,K-ATPase. J Neurosci 1991, 11:381-391.
3. Bøttger P, Tracz Z, Heuck A, Nissen P, Romero-Ramos M, Lykke-Hartmann K Distribution of Na/K-ATPase alpha 3 isoform, a sodium-potassium P-type pump associated with rapid-onset of dystonia parkinsonism (RDP) in the adult mouse brain. J Comp Neurol 2011, 519:376-404.
4. Dobretsov M, Stimers JR Neuronal function and alpha3 isoform of the Na/K-ATPase. Front Biosci 2005, 10:2373-2396.
5. Dobretsov M, Hastings SL, Sims TJ, Stimers JR, Romanovsky D Stretch receptor-associated expression of alpha 3 isoform of the Na+, K+-ATPase in rat peripheral nervous system. Neuroscience 2003, 116:1069-1080.
6. Crambert G, Hasler U, Beggah AT, et al. Transport and pharmacological properties of nine different human Na, K-ATPase isozymes. J Biol Chem 2000, 275:1976-1986.
7. Senatorov VV, Mooney D, Hu B The electrogenic effects of Na(+)-K(+)-ATPase in rat auditory thalamus. J Physiol 1997, 502:375-385.
8. Vaillend C, Mason SE, Cuttle MF, Alger BE Mechanisms of neuronal hyperexcitability caused by partial inhibition of Na+-K+-ATPases in the rat CA1 hippocampal region. J Neurophysiol 2002, 88:2963-2978.
9. Shiina N, Yamaguchi K, Tokunaga M RNG105 deficiency impairs the dendritic localization of mRNAs for Na+/K+ ATPase subunit isoforms and leads to the degeneration of neuronal networks. J Neurosci 2010, 30:12816-12830.
10. Blom H, Rönnlund D, Scott L, et al. Spatial distribution of Na+-K+-ATPase in dendritic spines dissected by nanoscale superresolution STED microscopy. BMC Neurosci 2011, 12:16.
11. Rose CR, Konnerth A NMDA receptor-mediated Na+ signals in spines and dendrites. J Neurosci 2001, 21:4207-4214.
12. +-ATPase. Cell Mol Life Sci 2013, 70:205-222.
13. Brashear A, DeLeon D, Bressman SB, Thyagarajan D, Farlow MR, Dobyns WB Rapid-onset dystonia-parkinsonism in a second family. Neurology 1997, 48:1066-1069.
14. Dobyns WB, Ozelius LJ, Kramer PL, et al. Rapid-onset dystonia-parkinsonism. Neurology 1993, 43:2596-2602.
15. Kramer PL, Mineta M, Klein C, et al. Rapid-onset dystonia-parkinsonism: linkage to chromosome 19q13. Ann Neurol 1999, 46:176-182.
16. Pittock SJ, Joyce C, O'Keane V, et al. Rapid-onset dystonia-parkinsonism: a clinical and genetic analysis of a new kindred. Neurology 2000, 55:991-995.
17. Zaremba J, Mierzewska H, Lysiak Z, Kramer P, Ozelius LJ, Brashear A Rapid-onset dystonia-parkinsonism: a fourth family consistent with linkage to chromosome 19q13. Mov Disord 2004, 19:1506-1510.
18. de Carvalho Aguiar P, Sweadner KJ, Penniston JT, et al. Mutations in the Na+/K+ -ATPase alpha3 gene ATP1A3 are associated with rapid-onset dystonia parkinsonism. Neuron 2004, 43:169-175.
19. Brashear A, Dobyns WB, de Carvalho Aguiar P, et al. The phenotypic spectrum of rapid-onset dystonia-parkinsonism (RDP) and mutations in the ATP1A3 gene. Brain 2007, 130:828-835.
20. McKeon A, Ozelius LJ, Hardiman O, Greenway MJ, Pittock SJ Heterogeneity of presentation and outcome in the Irish rapid-onset dystonia-parkinsonism kindred. Mov Disord 2007, 22:1325-1327.
21. Barbano RL, Hill DF, Snively BM, et al. New triggers and non-motor findings in a family with rapid-onset dystonia-parkinsonism. Parkinsonism Relat Disord 2012, 18:737-741.
22. Lee JY, Gollamudi S, Ozelius LJ, Kim JY, Jeon BS ATP1A3 mutation in the first Asian case of rapid-onset dystonia-parkinsonism. Mov Disord 2007, 22:1808-1809.
23. Zanotti-Fregonara P, Vidailhet M, Kas A, et al. [123I]-FP-CIT and [99mTc]-HMPAO single photon emission computed tomography in a new sporadic case of rapid-onset dystonia-parkinsonism. J Neurol Sci 2008, 273:148-151.
24. Blanco-Arias P, Einholm AP, Mamsa H, et al. A C-terminal mutation of ATP1A3 underscores the crucial role of sodium affinity in the pathophysiology of rapid-onset dystonia-parkinsonism. Hum Mol Genet 2009, 18:2370-2377.
25. Anselm IA, Sweadner KJ, Gollamudi S, Ozelius LJ, Darras BT Rapid-onset dystonia-parkinsonism in a child with a novel ATP1A3 gene mutation. Neurology 2009, 73:400-401.
26. Svetel M, Ozelius LJ, Buckley A, et al. Rapid-onset dystonia-parkinsonism: case report. J Neurol 2010, 257:472-474.
27. Kamm C, Fogel W, Wåchter T, et al. Novel ATP1A3 mutation in a sporadic RDP patient with minimal benefit from deep brain stimulation. Neurology 2008, 70:1501-1503.
28. Tarsy D, Sweadner KJ, Song PC Case records of the Massachusetts General Hospital. Case 17-2010 - a 29-year-old woman with flexion of the left hand and foot and difficulty speaking. N Engl J Med 2010, 362:2213-2219.
29. Roubergue A, Roze E, Vuillaumier-Barrot S, et al. The multiple faces of the ATP1A3-related dystonic movement disorder. Mov Disord 2013, 28:1457-1459.
30. Brashear A, Mink JW, Hill DF, et al. ATP1A3 mutations in infants: a new rapid-onset dystonia-Parkinsonism phenotype characterized by motor delay and ataxia. Dev Med Child Neurol 2012, 54:1065-1067.
31. Heinzen EL, Swoboda KJ, Hitomi Y, et al. De novo mutations in ATP1A3 cause alternating hemiplegia of childhood. Nat Genet 2012, 44:1030-1034. the European Alternating Hemiplegia of Childhood (AHC) Genetics Consortium, the Biobanca e Registro Clinico per l'Emiplegia Alternante (I.B.AHC) Consortiumthe Biobanca e Registro Clinico per l'Emiplegia Alternante (I.B.AHC) Consortium, the European Network for Research on Alternating Hemiplegia (ENRAH) for Small and Medium-sized Enterpriese (SMEs) Consortiumthe European Network for Research on Alternating Hemiplegia (ENRAH) for Small and Medium-sized Enterpriese (SMEs) Consortium.
32. Rosewich H, Thiele H, Ohlenbusch A, et al. Heterozygous de-novo mutations in ATP1A3 in patients with alternating hemiplegia of childhood: a whole-exome sequencing gene-identification study. Lancet Neurol 2012, 11:764-773.
33. Ishii A, Saito Y, Mitsui J, et al. Identification of ATP1A3 mutations by exome sequencing as the cause of alternating hemiplegia of childhood in Japanese patients. PLoS One 2013, 8:e56120.
34. Hoei-Hansen CE, Dali CI, Lyngbye TJ, Duno M, Uldall P Alternating hemiplegia of childhood in Denmark: clinical manifestations and ATP1A3 mutation status. Eur J Paediatr Neurol 2014, 18:50-54.
35. Kamphuis DJ, Koelman H, Lees AJ, Tijssen MA Sporadic rapid-onset dystonia-parkinsonism presenting as Parkinson's disease. Mov Disord 2006, 21:118-119.
36. Brashear A, Hill DF, Snively B, Sweadner KJ, Ozelius L Denovo and recurrent mutations in ATP1A3 are common in rapid-onset dystonia-parkinsonism. Neurology 2010, 74(suppl 2):A204.
37. Petrovski S, Wang Q, Heinzen EL, Allen AS, Goldstein DB Genic intolerance to functional variation and the interpretation of personal genomes. PLoS Genet 2013, 9:e1003709.
38. Brashear A, Farlow MR, Butler IJ, Kasarskis EJ, Dobyns WB Variable phenotype of rapid-onset dystonia-parkinsonism. Mov Disord 1996, 11:151-156.
39. Brashear A, Butler IJ, Ozelius LJ, et al. Rapid-onset dystonia-parkinsonism: a report of clinical, biochemical, and genetic studies in two families. Adv Neurol 1998, 78:335-339.
40. Brashear A, Butler IJ, Hyland K, Farlow MR, Dobyns WB Cerebrospinal fluid homovanillic acid levels in rapid-onset dystonia-parkinsonism. Ann Neurol 1998, 43:521-526.
41. Brashear A, Cook JF, Hill DF, et al. Psychiatric disorders in rapid-onset dystonia-parkinsonism. Neurology 2012, 79:1168-1173.
42. Bourgeois M, Aicardi J, Goutières F Alternating hemiplegia of childhood. J Pediatr 1993, 122:673-679.
43. Neville BG, Ninan M The treatment and management of alternating hemiplegia of childhood. Dev Med Child Neurol 2007, 49:777-780.
44. Sweney MT, Silver K, Gerard-Blanluet M, et al. Alternating hemiplegia of childhood: early characteristics and evolution of a neurodevelopmental syndrome. Pediatrics 2009, 123:e534-e541.
45. Silver K, Andermann F Alternating hemiplegia of childhood: a study of 10 patients and results of flunarizine treatment. Neurology 1993, 43:36-41.
46. Casaer P Flunarizine in alternating hemiplegia in childhood. An international study in 12 children. Neuropediatrics 1987, 18:191-195.
47. Casaer P, Azou M Flunarizine in alternating hemiplegia in childhood. Lancet 1984, 2:579.
48. Sasaki M, Sakuragawa N, Osawa M Long-term effect of flunarizine on patients with alternating hemiplegia of childhood in Japan. Brain Dev 2001, 23:303-305.
49. Kanavakis E, Xaidara A, Papathanasiou-Klontza D, Papadimitriou A, Velentza S, Youroukos S Alternating hemiplegia of childhood: a syndrome inherited with an autosomal dominant trait. Dev Med Child Neurol 2003, 45:833-836.
50. Bassi MT, Bresolin N, Tonelli A, et al. A novel mutation in the ATP1A2 gene causes alternating hemiplegia of childhood. J Med Genet 2004, 41:621-628.
51. Swoboda KJ, Kanavakis E, Xaidara A, et al. Alternating hemiplegia of childhood or familial hemiplegic migraine? A novel ATP1A2 mutation. Ann Neurol 2004, 55:884-887.
52. Andermann E, Andermann F, Silver K, Levin S, Arnold D Benign familial nocturnal alternating hemiplegia of childhood. Neurology 1994, 44:1812-1814.
53. Wagener-Schimmel LJ, Nicolai J Child neurology: benign nocturnal alternating hemiplegia of childhood. Neurology 2012, 79:e161-e163.
54. Mikati MA, Kramer U, Zupanc ML, Shanahan RJ Alternating hemiplegia of childhood: clinical manifestations and long-term outcome. Pediatr Neurol 2000, 23:134-141.
55. Saito Y, Sakuragawa N, Sasaki M, Sugai K, Hashimoto T A case of alternating hemiplegia of childhood with cerebellar atrophy. Pediatr Neurol 1998, 19:65-68.
56. Saito Y, Inui T, Sakakibara T, Sugai K, Sakuma H, Sasaki M Evolution of hemiplegic attacks and epileptic seizures in alternating hemiplegia of childhood. Epilepsy Res 2010, 90:248-258.
57. Dangond F, Garada B, Murawski BJ, Rey-Casserly C, Holman BL, Mikati MA Focal brain dysfunction in a 41-year old man with familial alternating hemiplegia. Eur Arch Psychiatry Clin Neurosci 1997, 247:35-41.
58. Mikati M Alternating hemiplegia of childhood. Pediatr Neurol 1999, 21:764.
59. Panagiotakaki E, Gobbi G, Neville B, et al. Evidence of a non-progressive course of alternating hemiplegia of childhood: study of a large cohort of children and adults. Brain 2010, 133:3598-3610. the ENRAH Consortium.
60. Verret S, Steele JC Alternating hemiplegia in childhood: a report of eight patients with complicated migraine beginning in infancy. Pediatrics 1971, 47:675-680.
61. Krägeloh I, Aicardi J Alternating hemiplegia in infants: report of five cases. Dev Med Child Neurol 1980, 22:784-791.
62. Mikati MA, Maguire H, Barlow CF, et al. A syndrome of autosomal dominant alternating hemiplegia: clinical presentation mimicking intractable epilepsy; chromosomal studies; and physiologic investigations. Neurology 1992, 42:2251-2257.
63. Sasaki M, Ishii A, Saito Y, et al. Genotype-phenotype correlations in alternating hemiplegia of childhood. Neurology 2014, 82:482-490.
64. Di Michele M, Goubau C, Waelkens E, et al. Functional studies and proteomics in platelets and fibroblasts reveal a lysosomal defect with increased cathepsin-dependent apoptosis in ATP1A3 defective alternating hemiplegia of childhood. J Proteomics 2013, 86:53-69.
65. Post RL, Hegyvary C, Kume S Activation by adenosine triphosphate in the phosphorylation kinetics of sodium and potassium ion transport adenosine triphosphatase. J Biol Chem 1972, 247:6530-6540.
66. +-ATPase mutants causing neurological disease. J Biol Chem 2014, 289:3186-3197.
67. Koenderink JB, Geibel S, Grabsch E, De Pont JJ, Bamberg E, Friedrich T Electrophysiological analysis of the mutated Na,K-ATPase cation binding pocket. J Biol Chem 2003, 278:51213-51222.
68. Poulsen H, Khandelia H, Morth JP, et al. Neurological disease mutations compromise a C-terminal ion pathway in the Na(+)/K(+)-ATPase. Nature 2010, 467:99-102.
69. Toustrup-Jensen M, Vilsen B Importance of Glu(282) in transmembrane segment M3 of the Na(+),K(+)-ATPase for control of cation interaction and conformational changes. J Biol Chem 2002, 277:38607-38617.
70. + interaction by distinct mechanisms. J Biol Chem 2006, 281:18539-18548.
71. + site. J Biol Chem 2010, 285:26245-26254.
72. +-ATPase) with bound potassium and ouabain. Proc Natl Acad Sci USA 2009, 106:13742-13747.
73. +-ATPase α3 missense mutant mice. PLoS One 2013, 8:e60141.
74. Kaneko M, Desai BS, Cook B Ionic leakage underlies a gain-of-function effect of dominant disease mutations affecting diverse P-type ATPases. Nat Genet 2014, 46:144-151.
75. Clapcote SJ, Duffy S, Xie G, et al. Mutation I810N in the α3 isoform of Na+,K+-ATPase causes impairments in the sodium pump and hyperexcitability in the CNS. Proc Natl Acad Sci USA 2009, 106:14085-14090.
76. Moseley AE, Williams MT, Schaefer TL, et al. Deficiency in Na,K-ATPase alpha isoform genes alters spatial learning, motor activity, and anxiety in mice. J Neurosci 2007, 27:616-626.
77. DeAndrade MP, Yokoi F, van Groen T, Lingrel JB, Li Y Characterization of Atp1a3 mutant mice as a model of rapid-onset dystonia with parkinsonism. Behav Brain Res 2011, 216:659-665.
78. Ikeda K, Satake S, Onaka T, et al. Enhanced inhibitory neurotransmission in the cerebellar cortex of Atp1a3-deficient heterozygous mice. J Physiol 2013, 591:3433-3449.
79. Ashmore LJ, Hrizo SL, Paul SM, Van Voorhies WA, Beitel GJ, Palladino MJ Novel mutations affecting the Na, K ATPase alpha model complex neurological diseases and implicate the sodium pump in increased longevity. Hum Genet 2009, 126:431-447.
80. Doǧanli C, Beck HC, Ribera AB, Oxvig C, Lykke-Hartmann K α3Na+/K+-ATPase deficiency causes brain ventricle dilation and abrupt embryonic motility in zebrafish. J Biol Chem 2013, 288:8862-8874.
81. +-ATPase α3 sodium pump. Proc Natl Acad Sci USA 2011, 108:18144-18149.
82. +-ATPase activity in Atp1a3 heterozygous mice increases susceptibility to depression-like endophenotypes by chronic variable stress. Genes Brain Behav 2011, 10:542-550.
83. +-ATPase alterations in ouabain and adducin-dependent hypertension. Am J Physiol Regul Integr Comp Physiol 2006, 290:R529-R535.
84. Pizoli CE, Jinnah HA, Billingsley ML, Hess EJ Abnormal cerebellar signaling induces dystonia in mice. J Neurosci 2002, 22:7825-7833.
85. Calderon DP, Fremont R, Kraenzlin F, Khodakhah K The neural substrates of rapid-onset dystonia-parkinsonism. Nat Neurosci 2011, 14:357-365.
86. +-ATPase. Biochim Biophys Acta 1989, 988:185-220.
87. Rajarao SJ, Canfield VA, Mohideen MA, et al. The repertoire of Na,K-ATPase alpha and beta subunit genes expressed in the zebrafish, Danio rerio. Genome Res 2001, 11:1211-1220.
88. +)-ATPase alpha-subunit in Drosophila melanogaster. EMBO J 1989, 8:193-202.
89. + ATPase alpha subunit mutants. J Neurosci 2003, 23:1276-1286.